Hepatic Failure following Metronidazole in Children with Cockayne Syndrome.

Case Rep Pediatr

Pediatric Gastroenterology and Hepatology Research Center, Tehran University of Medical Sciences, Department of Pediatric, Bahrami Children's Hospital, Tehran, Iran.

Published: January 2020

Cockayne syndrome is an uncommon autosomal recessive disease characterized by microcephaly, abnormal growth, and pathologic premature aging. The purpose of this report is to evaluate liver failure in children with Cockayne syndrome following metronidazole administration. The first case was a 2-year-old boy with Cockayne syndrome. He had been treated with metronidazole for gastroenteritis. 48 hours after treatment initiation, he was hospitalized due to jaundice, intractable vomiting, and agitation. Unfortunately, he died of acute liver failure. The second case was a 5-year-old boy with Cockayne syndrome as well, who had been treated with amoxicillin and metronidazole for a dental infection. He developed jaundice, drowsiness, lethargy, and anorexia after treatment. At hospital, the child received supportive treatment, and his general condition gradually improved. The liver enzyme levels decreased. He was finally discharged in good general condition. The mortality after metronidazole consumption in patients with Cockayne syndrome due to liver failure is very high. The awareness of the dangers of using metronidazole in these patients is valuable.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008298PMC
http://dx.doi.org/10.1155/2020/9634196DOI Listing

Publication Analysis

Top Keywords

cockayne syndrome
24
liver failure
12
children cockayne
8
boy cockayne
8
general condition
8
metronidazole
6
cockayne
6
syndrome
6
hepatic failure
4
failure metronidazole
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!